L9, Signalopathies I Flashcards
1
Q
Key neurodegenerative diseases caused by calcium signalling dysregulation:
A
- AD
- PD
- HD
- Prion disease
2
Q
Types of AD:
A
- Late-onset: After 65yrs, most common
- Early-onset: 30-65, rare, often progresses more rapidly than late-onset AD
3
Q
A
4
Q
Hallmarks of AD:
A
Formation of neurofibrillary tangles:
- Phosphorylation of tau protein by GSK-3
- Aggregation of phosphorylated tau proteins into tangles
- Removal of tau protein interferes with neuronal transport (destabilising microtubules)
Amyloid plaques: (outside neurons)
- Cleavage of amyloid precursor protein (APP) -> beta amyloid fibres
- Polymerisation of AB fibres -> beta amyloid plaques
- Abnormal amyloid levels bring about neuronal cell death
5
Q
Classifications of AD:
A
- Familial AD (follows a certain inheritance pattern)
- Sporadic AD: Amyloidogenic pathway + Ca2+ signalosome remodelling with age -> severe cognitive decline + neuronal cell death
6
Q
Amyloid cascade hypothesis (Non-amyloidogenic pathways):
A
- Beta amyloid precursor protein synthesised in the ER-golgi, transferred to the PM
- APP cleaved by alpha-secretases -> soluble APPa and the C terminal fragment a in the membrane
- CTFa hydrolysed by PS1 releasing APP intracellular domain (a TF)
- APP is recycled through endosomal pathway -> No AB release
7
Q
Amyloid cascade hypothesis (Amyloidogenic pathways):
A
- Internalised APP is cleaved by B-secretases (part of BACE) to produce the C-terminal fragment B
- CTF is hydrolysed by gamma-secretase releasing AB (and AICD)
- Aggregation of AB monomers to form AB oligomers, fibrils and plaques
- Interaction of AB oligomers with the cellular prion protein (PrPc) -> apoptosis
- N-terminal sAPPB is hydrolysed to N-terminal APP (N-APP)
- N-APP (through the DR6 receptor) activates caspases-3 (leading to apoptosis) ad caspase-6 (leading to axon pruning)
8
Q
How do AB oligomers cause calcium influx?
A
- Cellular prion protein interaction allows receptor action -> Ca2+ influx
- AB oligomer insert into membrane to form channels -> Ca2+ influx
- Enhance Ca2+ entry through ROCs: NMDA receptor (NMDAR)
9
Q
A
10
Q
Presenilins: Role in calcium release
A
- PS ‘leak Calcium from the ER (pressure valve), maintaining ER calcium at a low level (hippocampal dendrite spine cytosol via SOCs)
11
Q
Mutations in PS1 that cause early onset FAD:
A
- Increased Calcium release from ER
- Reduce Calcium influx into hippocampal spines via SOCs
- Enhance IP3R/RYR-mediated Calcium release due to beta-amyloid
12
Q
Role of ROS in calcium release:
A
- Act as IP3R agonist
13
Q
Consequence of Calcium dysregulation in AD:
A
- Calcium-induced apoptosis
- Calcium/ROS-associated astrocyte-induced neuronal cell death (astrocytes support neurons in the CNS)
- Disruption of synaptic plasticity, learning and memory
14
Q
How is calcium involved in apoptosis?
A
- Increase in cytosolic calcium
- Release of mitochondrial cytochrome c
- Apoptosome formation; caspase activation, cleavage of proteins and DNA
15
Q
How does disruption of calcium homeostasis disrupt synaptic plasticity?
A
- Synapses undergo modifications of synaptic efficiency
- Calcium induced changes in the sensitivity of the AMPA receptor (AMPAR) to glutamate in dendritic spines (LTP and LTD)
- High calcium: Phosphorylation by activated CaMKII and enhanced sensitivity to glutamate -> LTP and memory formation
- Low calcium increases: Dephosph. by activated CaN, reduced sensitivity to glutamate -> LTD and erasure of temporary memory (overactive in AD patients since basal calcium is constantly elevated)